A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung (LCNEC-ALPINE)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05470595 |
|
Recruitment Status :
Recruiting
First Posted : July 22, 2022
Last Update Posted : November 2, 2023
|
Sponsor:
Technische Universität Dresden
Collaborator:
Roche Pharma AG
Information provided by (Responsible Party):
Technische Universität Dresden
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | January 31, 2028 |
| Estimated Study Completion Date : | January 31, 2029 |